Saniona

Saniona is a clinical-stage biopharmaceutical company focused on the discovery and development of innovative treatments for neurological and psychiatric disorders, such as epilepsy and severe depression. The company leverages a proprietary ion-channel drug discovery engine to create selective, subtype-specific, state-dependent ion channel modulators. Headquartered in Denmark, Saniona has transitioned from a partnership-heavy validation phase to a focused clinical execution strategy. The company maintains strategic partnerships with major pharmaceutical entities, including Jazz Pharmaceuticals and Acadia Pharmaceuticals, to advance its pipeline assets while focusing its internal efforts on proprietary programs.